This is a working overview of clinical endpoint, written for readers who want more than a one-paragraph summary but less than a textbook.
Reviewed 2026-01-09. Anything still debated is marked as such rather than presented as settled.
Retatrutide is an investigational synthetic peptide engineered to activate three distinct hormone receptors within a single molecule. It targets the glucose-dependent insulinotropic polypeptide receptor, the glucagon-like peptide-1 receptor, and the glucagon receptor simultaneously. This triagonist design distinguishes it from earlier incretin-based compounds that act on one or two of these pathways. Structural modifications relative to native gut hormones extend its residence time in circulation. The molecule remains under clinical evaluation and is not approved for any indication.
Receptor activation produces downstream effects that differ by tissue. GLP-1 receptor signaling influences appetite regulation and insulin secretion in a glucose-dependent manner. GIP receptor activity contributes to metabolic handling of nutrients and may modulate adipose tissue. Glucagon receptor engagement raises energy expenditure and promotes hepatic lipid turnover, though the balance among these actions in humans is still being characterized. Preclinical models showed reductions in body weight and improved glycemic markers.
Quantification of the peptide in biological samples generally relies on liquid chromatography coupled with tandem mass spectrometry. This approach separates the analyte from matrix components and detects it by mass-to-charge transitions specific to the molecule. Immunoassays offer higher throughput but can cross-react with related peptides and metabolites, so mass spectrometric methods are preferred when structural confirmation is required. Method validation typically addresses accuracy, precision, selectivity, and stability under handling conditions.
Several questions remain unresolved. It is not yet known whether the compound reduces cardiovascular events or mortality, because outcome studies require long follow-up. The durability of weight reduction after treatment withdrawal is uncertain, and rebound has been observed with other incretin-based therapies. Long-term safety data covering several years are limited. Effects in adolescents, in pregnancy, and in people with significant kidney or liver impairment have not been characterized in published reports.
| Property | Value | Notes |
|---|---|---|
| Receptor targets | GIP, GLP-1, glucagon | One molecule activates all three pathways |
| Research identifier | LY3437943 | Code used in published trial reports |
| Development stage | Phase 3, reported as ongoing | Not approved by any regulatory agency |
| Route studied | Subcutaneous | Administration form used in clinical trials |
| Studied populations | Adults with obesity or type 2 diabetes | Enrollment criteria vary between trials |
Clinical studies have reported notable reductions in body weight among participants. Early trials measured safety and explored several dose levels, and later studies tracked body-weight change over months of treatment. Investigators also monitor effects on glycemic markers, liver fat, and blood lipids. Because the compound is still in development, questions about long-term safety, cardiovascular outcomes, and durability after treatment ends remain open.
The three-receptor design places retatrutide in a distinct category relative to older incretin-based therapies. Single agonists target one receptor, and dual agonists target two. Adding a third target broadens the pharmacological footprint and introduces new trade-offs among efficacy, tolerability, and glucose control. How these trade-offs resolve in large trials is a central focus of current research.
Retatrutide is an investigational peptide studied for obesity and type 2 diabetes. It is a single synthetic molecule designed to activate three metabolic receptors simultaneously. The compound belongs to the incretin mimetic family, a group of peptides that imitate gut hormones involved in appetite and glucose control. Its research code is LY3437943, and it remains under clinical study rather than cleared for routine medical use.
Material handling focuses on limiting degradation. Lyophilized powder is generally stored at reduced temperature, often around minus twenty degrees Celsius, protected from light and moisture. Once dissolved, the peptide is less stable and is commonly kept cold and used within a short window. Repeated freeze-thaw cycles promote aggregation and should be avoided. Buffers and pH influence stability, and solution conditions are usually selected to keep the peptide near neutral pH where degradation proceeds more slowly. These practices apply to laboratory reference material, not to clinical preparations.
Verification of research-grade material depends on documentation supplied with a sample. A certificate of analysis lists purity, identity, and the methods used to establish each value. Buyers comparing suppliers look at chromatographic purity figures, mass confirmation data, and whether methods are described in enough detail to be reproduced. Independent testing can confirm reported values but adds cost and time. Because the research chemical market is not uniformly regulated, provenance and documentation quality vary widely, and claims should be evaluated against raw data rather than summary labels.
RNA replication is the copying of one RNA to another. Many viruses replicate this way. The enzymes that copy RNA to new RNA, called RNA-dependent RNA polymerases, are also found in many eukaryotes, where they are involved in RNA silencing. RNA editing, in which an RNA sequence is altered by a complex of proteins and a "guide RNA", could also be seen as an RNA-to-RNA transfer.
==== Persistent pulmonary hypertension ==== Persistent pulmonary hypertension (PPHN) is a serious and life-threatening, but very rare, lung condition that occurs soon after the birth of the newborn. Newborn babies with PPHN have high pressure in their lung blood vessels and are not able to get enough oxygen into their bloodstream. About 1 to 2 babies per 1000 babies born in the U.S. develop PPHN shortly after birth, and often they need intensive medical care. It is associated with about a 25% risk of significant long-term neurological deficits. A 2014 meta analysis found no increased risk of persistent pulmonary hypertension associated with exposure to SSRIs in early pregnancy and a slight increase in risk associates with exposure late in pregnancy; "an estimated 286 to 351 women would need to be treated with an SSRI in late pregnancy to result in an average of one additional case of persistent pulmonary hypertension of the newborn". A review published in 2012 reached conclusions similar to those of the 2014 study.
== Personal life == Duterte is known for being an avid fan of large-displacement cruiser motorcycles, but detests luxury cars. He owns a Harley-Davidson Street and a Can-Am Spyder. He was once a habitual smoker, but he eventually quit after a doctor's suggestion due to health concerns. Duterte is an avid reader of Robert Ludlum and Sidney Sheldon novels. Duterte is also known for his straightforward and vocal attitude in public, especially in interviews, showing no hesitation in profusely using profanity live on-screen on numerous occasions despite formal requests by media groups and schools beforehand to abstain. Duterte has his own local show in Davao City called Gikan sa Masa, para sa Masa ("From the Masses, For the Masses"), which formerly aired as a blocktimer on ABS-CBN Davao, and currently broadcast on SMNI News Channel since 2023. He is also a member of Lex Talionis Fraternitas, a fraternity based in the San Beda College of Law and the Ateneo de Davao University. Aside from his native Cebuano, Duterte is also fluent in Filipino and English. While criticizing political opponent Antonio Trillanes in a 2019 speech, Duterte claimed that he was once gay but had "cured himself" before meeting his wife Elizabeth Zimmerman. Since being the mayor of Davao City, Duterte has held an annual tradition of visiting children with cancer in the city and giving them Christmas gifts. Duterte is a self-proclaimed womanizer who had other women besides his former wife Elizabeth Zimmerman and current domestic partner Honeylet Avanceña.
== History == Glenmark was incorporated on 18 November 1977. It began producing generic drugs and active pharmaceutical ingredients for markets in India, Russia, and Africa, and went public on Indian stock exchanges in 1999. Glenn Saldanha, Gracias's son, became managing director in 2001 after working at Eli Lilly and Company and PricewaterhouseCoopers. Under his leadership the company expanded internationally; by 2008 it had become one of India's larger pharmaceutical manufacturers by sales volume, and in 2011 consolidated worldwide sales reached $778 million. That year Glenmark established its first North American manufacturing facility in Monroe, North Carolina. In the mid-2010s, Glenmark changed direction. The generic drug industry was seeing fewer patent expirations, and the company began developing proprietary medicines in oncology, dermatology, and respiratory treatments. It researched drugs internally and licensed them to larger pharmaceutical companies. By 2016, four Glenmark drugs were in clinical development. A respiratory treatment was licensed for commercialisation in North America and Japan, and a diabetes drug was licensed to Merck's German division. Sales that fiscal year were approximately ₹81 billion (about $1.25 billion), ranking it fourth among India's pharmaceutical manufacturers by revenue. Glenmark built a consumer healthcare business in India that included the antifungal Candid, launched in 1979, the respiratory medication Ascoril, and La Shield. It divested the intimate hygiene brand VWash to Hindustan Unilever in March 2020.
Sources: en.wikipedia.org
Pauling was awarded the International Lenin Peace Prize by the USSR in 1970. He continued his peace activism in the following years. He and his wife Ava helped to found the International League of Humanists in 1974. He was president of the scientific advisory board of the World Union for Protection of Life and also one of the signatories of the Dubrovnik–Philadelphia statement of 1974/1976. Linus Carl Pauling was an honorary president and member of the International Academy of Science, Munich, until the end of his life. Pauling was also a supporter of the Fair Play for Cuba Committee.
==== Lebanon ==== Dunkin' opened its first location in Lebanon in 1998 and has since gained a lot of admiration among Lebanese people and is now one of the most popular coffee shops with many branches spread across the country. In 2020, Dunkin' Lebanon started selling its products in supermarkets and grocery stores.
The need for fuel declined in the Soviet Union from the 1970s to the 1980s, both per ruble of gross social product and per ruble of industrial product. The decline was very rapid between 1965 and 1970, then slowed between 1970 and 1975. From 1975 to 1980, the decline continued at an even slower rate, with fuel requirements per ruble of gross social product decreasing by only 2.6%. David Wilson, a historian, believed that the gas industry would account for 40% of Soviet fuel production by the end of the century. His theory did not come to fruition because of the USSR's collapse. According to Wilson, the Soviet Union was, in theory, well-positioned to avoid an energy crisis and could have sustained economic growth rates of 2–2.5% during the 1990s, supported by its energy resources. However, the energy sector faced many difficulties, among them the country's high military expenditure and hostile relations with the First World. In 1991, the Soviet Union had a pipeline network of 82,000 kilometres (51,000 mi) for crude oil and another 206,500 kilometres (128,300 mi) for natural gas. Petroleum and petroleum-based products, natural gas, metals, wood, agricultural products, and a variety of manufactured goods, primarily machinery, arms and military equipment, were exported. In the 1970s and 1980s, the USSR heavily relied on fossil fuel exports to earn hard currency. At its peak in 1988, it was the largest producer and second-largest exporter of crude oil, surpassed only by Saudi Arabia.
=== Parasites === Emus can suffer from both external and internal parasites, but under farmed conditions are more parasite-free than ostriches or rheas. External parasites include the louse Dahlemhornia asymmetrica and various other lice, ticks, mites and flies. Chicks sometimes suffer from intestinal tract infections caused by coccidian protozoa, and the nematode Trichostrongylus tenuis infects the emu as well as a wide range of other birds, causing haemorrhagic diarrhoea. Other nematodes are found in the trachea and bronchi; Syngamus trachea causing haemorrhagic tracheitis and Cyathostoma variegatum causing serious respiratory problems in juveniles.
The byproducts of food fermentation are alcohol, preservative organic acids, and carbon dioxide, all three of which have found human uses. The production of alcohol results in fruit juices becoming wine, grains becoming beer, and foods rich in starch, such as potatoes, that are then distilled into spirits like gin and vodka. The production of carbon dioxide is used to leaven bread. The production of organic acids is exploited to preserve and flavor vegetables and dairy products. Food fermentation serves five main purposes: to enrich the diet through development of a diversity of flavors, aromas, and textures in food substrates; To preserve substantial amounts of food through lactic acid, alcohol, acetic acid, and alkaline fermentations; to enrich food substrates with protein, essential amino acids, and vitamins; to eliminate antinutrients; and to reduce cooking time and the associated use of fuel. Beverages produced through fermentation have likely been universally associated with ceremonies and festivals. There is some understanding of how they have been consumed in such contexts, derived from the construction of drinkware and the residue contained therein.
Sources: en.wikipedia.org
It is a synthetic peptide triagonist that engages GIP, GLP-1, and glucagon receptors. Investigational compounds in this class are studied for metabolic conditions rather than for a single organ system.
No regulatory agency has approved it for any indication. It remains an investigational product studied within controlled clinical trial programs.
A dual agonist engages two receptor targets, typically GIP and GLP-1. A triagonist adds glucagon receptor activity, which is intended to influence energy expenditure alongside appetite and glucose handling.
Trials measure percentage change in body weight, absolute weight loss, and glycemic markers such as hemoglobin A1c. They also record blood pressure, lipids, and liver fat. Adverse events are tracked throughout.